Hyperfine

Hyperfine Stock-Based Compensation

The Stock-Based Compensation (SBC) of Hyperfine (HYPR) as of Oct 22, 2026 is 2.80 M USD. In the previous year, Stock-Based Compensation (SBC) was 4.36 M USD — a change of -35.79% (lower).

Stock-Based Compensation

2.80 MUSD

YoY

-35.79%

Last updated:

Stock-Based Compensation (SBC) of Hyperfine is 2025 2.80 M USD. Stock-Based Compensation (SBC) of Hyperfine was 2024 4.36 M USD. It decreases by -35.79% lower compared to the previous year.

The Hyperfine Stock-Based Compensation history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Stock-Based Compensation
Date
Stock-Based Compensation
Jan 1, 2019
896,000.00 USD
Jan 1, 2020
1.12 M USD
Jan 1, 2021
6.90 M USD
Jan 1, 2022
10.65 M USD
Jan 1, 2023
4.74 M USD
Jan 1, 2024
4.36 M USD
Jan 1, 2025
2.80 M USD
The Hyperfine Stock-Based Compensation history
YEARStock-Based CompensationYoY
2.80 MUSD-35.79%
4.36 MUSD-7.99%
4.74 MUSD-55.49%
10.65 MUSD+54.35%
6.90 MUSD+517.82%
1.12 MUSD+24.67%
896,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hyperfine Stock analysis

What does Hyperfine do? Hyperfine, Inc. generates revenue by providing imaging and monitoring solutions through magnetic resonance imaging to revolutionize healthcare. The company offers the Swoop system, a portable magnetic resonance imaging system capable of delivering neuroimaging at the point of care. This product produces images at a lower magnetic field strength than conventional MRI scanners, addressing unmet needs in medical diagnosis, disease staging, and follow-up treatment. The firm monetizes its technology through a combination of hardware and Artificial intelligence-powered software services. The hardware utilizes modern computational power and deep learning advances, while the software addresses traditional ease-of-use and integration challenges. These offerings are designed for use in various clinical settings to image human anatomy and physiological processes, targeting the medical device market segment. Hyperfine is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hyperfine stock

Stock-Based Compensation (SBC) of Hyperfine is 2.80 M USD in 2025.

Stock-Based Compensation (SBC) of Hyperfine changed from 4.36 M USD to 2.80 M USD, representing a -35.79% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) Hyperfine since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s Hyperfine historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Hyperfine

All Key Metrics — Hyperfine